Beckman Coulter
This article was originally published in The Gray Sheet
Executive Summary
Ongoing efforts by hospital networks to standardize lab equipment for improved ease of use and cost savings leads to a "record" increase in supply agreements with integrated health networks in 2001, the blood testing instrument maker says. IHN contracts signed in 2001 are expected to generate $196.5 mil. over the next five years, including deals worth $103.5 mil. signed in the fourth quarter alone, according to Beckman Coulter. Corporate sales advance 10.1% to $578.3 mil. in the fourth quarter, boosting earnings by 12.3% to $48.3 mil., the firm reports Jan. 28. Separately, the Fullerton, California company rolls out its CEQ 8000 automated, integrated genetic analysis system for high-speed DNA sequencing, heterozygote detection, confirmatory sequencing, mutation analysis, allele identification, SNP scoring, microsatellite instability and amplified fragment length polymorphism fingerprinting...